Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
Mirum Pharmaceuticals’ Livmarli Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis
(BUSINESS WIRE) March 13, 2024 -- Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved...
Praluent (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the U.S. Food & Drug Administration (FDA) has extended the approval of Praluent® (alirocumab)...
Wegovy Approved in the US for Cardiovascular Risk Reduction in People with Overweight or Obesity and Established Cardiovascular Disease
Bagsværd, Denmark, 8 March 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion...
FDA Approves Tyenne (tocilizumab-aazg), a Biosimilar to Actemra
Fresenius Kabi, a global health care company that specializes in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for...
New Immune-Focused Therapy Shrinks Aggressive Brain Tumors
Delivering dual-targeted, immune-focused CAR T cancer therapy via a patient's spinal fluid quickly shrank deadly brain tumors, researchers report.CAR T...
HHS Opens Investigation into United Health Cyberattack
Following a cyberattack on one of the nation's largest health insurers that's thrown health care payments into disarray and likely exposed reams of private...
Colon Cancer Blood Test 83% Accurate in Spotting Tumors
An experimental blood test accurately detected colon cancer in more than 8 in 10 people confirmed to have the disease, researchers report.The test —...
Actress Olivia Munn Is Battling Breast Cancer
Actress and "X-Men" star Olivia Munn announced Wednesday that she has been fighting breast cancer.Posting on her Instagram account, beside a photo of herself...
Annual Indirect Economic Burden of Sickle Cell Disease Over $2 Million
Adults with sickle cell disease (SCD) are more likely to report employment loss, and caregivers of children with SCD report more missed days of work, according...
Disease Knowledge Limited Among Individuals With Type 2 Diabetes
There is considerable room for improvement of disease knowledge among individuals with type 2 diabetes (T2D), according to a study published online March...
Many U.S. Seniors Do Not Intend to Vaccinate Against RSV
Many U.S. seniors do not intend to vaccinate against respiratory syncytial virus (RSV) in the 2023 to 2024 season, according to a study published online...
Risk for A-Fib Increased With Consumption of Sugar-Sweetened and Diet Beverages
Consumption of >2 L/week of sugar-sweetened beverages (SSB) or artificially sweetened beverages (ASB) is associated with an increased risk for atrial...
Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia
OSAKA, Japan, and CAMBRIDGE, Massachusetts, March 13, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced positive topline results from a Phase 2,...
Delta-8-THC Use Reported by 11% of 12th Graders in 2023
Use of the psychoactive cannabis product is higher in states without existing delta-8 regulations or cannabis legalization, NIH-funded study finds. Approximately...
Vitamin D Plus Calcium: Good News, Bad News for Older Women
Women who've gone through menopause and hope that supplemental vitamin D plus calcium might shield them from disease may be disappointed by new data. A...
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates
March 12, 2024 – DUBLIN, Ireland – Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par),...
Recently Added
Recently added consumer and prescribing information: Tyenne, Wyost, Letybo, Simlandi, Amtagvi, Casgevy, Ogsiveo, DefenCath, Adzynma, Zituvimet
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Tyenne Tyenne (tocilizumab-aazg) is an interleukin-6 (IL-6) receptor antagonist biosimilar to Actemra used for treatment of rheumatoid arthritis...
- Wyost Wyost (denosumab-bbdz) is a RANK ligand (RANKL) inhibitor interchangeable biosimilar to Xgeva (denosumab) indicated for the prevention of...
- Jubbonti Jubbonti (denosumab-bbdz) is a RANK ligand (RANKL) inhibitor interchangeable biosimilar to Prolia (denosumab) used in the treatment of...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
- Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.
Drugs &
Pill
Interaction
Side
Conditions
Treatment
Compare
My Med
Discount
FDA
Price
Phonetic
Health